Abstract
Frontotemporal dementia (FTD) is one of the leading causes of dementia before age 65 and often manifests as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive aphasia). FTD's exact clinical presentation varies by culture, language, education, social norms, and other socioeconomic factors; current research and clinical practice, however, is mainly based on studies conducted in North America and Western Europe. Changes in diagnostic criteria and procedures as well as new or adapted cognitive tests are likely needed to take into consideration global diversity. This perspective paper by two professional interest areas of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment examines how increasing global diversity impacts the clinical presentation, screening, assessment, and diagnosis of FTD and its treatment and care. It subsequently provides recommendations to address immediate needs to advance global FTD research and clinical practice.
Original language | English (US) |
---|---|
Pages (from-to) | 5817-5836 |
Number of pages | 20 |
Journal | Alzheimer's and Dementia |
Volume | 19 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2023 |
Funding
Sanne Franzen is supported by ZonMW (#73305095007) and Health Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). Renelle Bourdage is supported by the IDEX Fellowship. Ignacio Illán-Gala is supported with funding from GBHI, Alzheimer's Association, and Alzheimer's Society (GBHI ALZ UK-21-720973 and AACSF-21-850193), as well as by the Instituto de Salud Carlos III (JR20/0018 and PI21/00791). Darby Morhardt receives funding from NIH/NIA, HRSA, and a private foundation. Jennifer S. Yokoyama is supported by NIH-NIA R01 AG062588, R01 AG057234, P30 AG062422; NIH-NINDS U54 NS123985; the Rainwater Charitable Foundation; the Alzheimer's Association; the Global Brain Health Institute; and the Mary Oakley Foundation. Jessica de Leon is supported by NIDCD K23 DC018021. Fiona Kumfor is supported by the National Health and Medical Research Council Career Development Fellowship GNT1158762. Andrea Slachevsky is supported by ANID/FONDAP /ID15150012; ANID/FONDEF/ID22I10251; ANID/Fondecyt Regular/1210195 &1191726; ANID/PIA/Anillos ACT210096; Multi-Partner-Consortium to expand dementia research in Latin-America (ReDLat, supported by National Institutes of Health, National Institutes of Aging [R01 AG057234], Alzheimer's Association [SG-20-725707], Tau Consortium, and Global Brain Health Institute), and Alzheimer's Association GBHI ALZ UK-20-639295. Aida Suarez-Gonzalez is funded by a UKRI Healthy Ageing Challenge Catalyst Award (ES/W006405/1), the National Institute for Health Research (COV-LT2-0014), and a grant jointly funded by the Economic and Social Research Council (UK) and the National Institute for Health Research (UK; ES/S010467/1). Elena Tsoy is supported by the Alzheimer's Association. Hülya Ulugut has received the Alzheimer's Association Clinician Scientist Fellowship (AACSF) grant (Re: AACSF-22-849085). Ganesh M. Babulal is supported by NIH/NIA: R01AG068183 (GMB), R01AG056466 (GMB), R01AG067428 (GMB), R01AG074302 (GMB), and BrightFocus Foundation A2021142S (GMB).
Keywords
- cultural diversity
- diagnosis
- ethnicity
- frontotemporal dementia
- language
- literacy
- neuropsychological tests
- primary progressive aphasia
ASJC Scopus subject areas
- Epidemiology
- Health Policy
- Developmental Neuroscience
- Clinical Neurology
- Geriatrics and Gerontology
- Cellular and Molecular Neuroscience
- Psychiatry and Mental health